Immunovant, Inc. (IMVT)

26.65 +0.37 (+1.41%) USD  |  NASDAQ  |  Feb 18, 16:00
26.63 -0.02 (-0.08%) After-Hours: 20:00
More

Immunovant Operating Income (Quarterly)

Operating Income (Quarterly) Chart

View Operating Income (Quarterly) for IMVT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Quarterly) Range, Past 5 Years

View Operating Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Quarterly) Benchmarks

View Operating Income (Quarterly) Benchmarks
Start Trial
Boston Scientific Corp. Upgrade
Viridian Therapeutics, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade
Nutriband, Inc. Upgrade
Definium Therapeutics, Inc. Upgrade